(Q72791961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

medroxyprogesterone acetate

29 October 2019

main subject

1 reference

1 reference

1 September 2023

1 reference

1 September 2023

author name string

C. M. Camaggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

E. Strocchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

M. Giovannini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

B. Angelelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

B. Costanti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

E. Zebini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

P. Ferrari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

F. Pannuti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6224604

1 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6224604

1 September 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

number of pages

4

1 reference

full work available at URL

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/BF00257410.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00257410/fulltext.html

1 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00257410

1 September 2023

1 reference

Cancer Chemotherapy and Pharmacology

1 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

19-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00257410

29 October 2019

exact match

0 references

cites work

The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer

1 reference

12 December 2020

High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy

1 reference

12 December 2020

Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1

1 reference

12 December 2020

High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response Evaluation

1 reference

12 December 2020

Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients

1 reference

12 December 2020

A radioimmunoassay for serum medroxyprogesterone acetate

1 reference

12 December 2020

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer

1 reference

12 December 2020

GLC Determination of Medroxyprogesterone Acetate in Plasma

1 reference

12 December 2020

Medroxyprogesterone acetate (MAP) relative bioavailability after single high-dose administration in cancer patients

1 reference

12 December 2020

Interaction between steroids and a uterine progestogen specific binding macromolecule.

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00257410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6224604%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference